[32] GIRARD YK, WANG C, RAVI S, et al. A 3D fibrous scaffold inducing tumoroids: a plaるorm for anticancer drug development. PLoS One.2013;8(10):e.

[33] Lu WD, SuN RF, Hu YR, et al. Photooxidatively crosslinked acellular tumor extracellular matrices as potential tumor engineering Biomater. 2018;71:460-473.

[34] LIu H, WANG N, zHANG z, et al. Effects of Tumor Necrosis Factor-α on Morphology and Mechanical Properties of HCT116 Human Colon Cancer Cells Investigated by Atomic Force Microscopy. 2017;2017:.

[35] WAN G, PEHLKE C, PEPERMANS R, et al. The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells. Scanning. 2015;1:.

[36] Fu RH, WANG YC, LIu SP, et al. Decellularization and recellularization technologies in tissue engineering. Cell Transplant. 2014;23(4-5):621-630.

[37] JENSEN T, ROSzELL B, zANG F, et al. A rapid lung de-cellularization protocol supports embryonic stem cell differentiation in vitro and following implantation. Tissue Eng Part C Methods. 2012;18(8):632-646.

[38] Wu J, DING Q, DuTTA A, et al. An injectable extracellular matrix derived hydrogel for meniscus repair and regeneration. Acta ;16:49-59.

[39] JuNTTILA MR, DE SAuVAGE FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346-354.

[40] SEO JS, KIM A, SHIN JY, et al. Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor. Sci Rep. 2018;8(1):.

文章来源：《肿瘤药学》 网址: http://www.zlyxzz.cn/qikandaodu/2021/0222/666.html